Soleus Capital Management, L.P. Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$175.4B
Holdings
60
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (60 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ZYMEWORKS INC | 748,736 | $27.0B | 15.40% | Put |
| 2 | EPIEURESSA PHARMA INC | 2,082,185 | $12.9B | 7.36% | |
| 3 | OPHTEURIVERIC BIO INC | 1,626,701 | $8.3B | 4.73% | |
| 4 | AZNASTRAZENECA PLC | 136,214 | $7.2B | 4.11% | |
| 5 | PRTAPROTHENA CORP PLC | 674,603 | $7.1B | 4.02% | |
| 6 | QDELUSDQUIDEL CORP | 30,900 | $6.9B | 3.94% | |
| 7 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 620,266 | $6.0B | 3.39% | |
| 8 | ALXNALEXION PHARMACEUTICALS INC | 50,789 | $5.7B | 3.25% | |
| 9 | SRPTSAREPTA THERAPEUTICS INC | 34,500 | $5.5B | 3.15% | |
| 10 | IRMDIRADIMED CORP | 212,436 | $4.9B | 2.81% | |
| 11 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 218,723 | $4.6B | 2.60% | |
| 12 | ZYXIQZYNEX INC | 176,541 | $4.4B | 2.50% | |
| 13 | —IMMUNOMEDICS INC | 119,000 | $4.2B | 2.40% | |
| 14 | DC4DEXCOM INC | 9,550 | $3.9B | 2.21% | |
| 15 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 369,852 | $3.4B | 1.95% | |
| 16 | LLYLILLY ELI & CO | 20,800 | $3.4B | 1.95% | |
| 17 | NVCRNOVOCURE LTD | 56,397 | $3.3B | 1.91% | |
| 18 | VCELVERICEL CORP | 238,532 | $3.3B | 1.88% | |
| 19 | NARIUSDINARI MED INC | 65,817 | $3.2B | 1.82% | |
| 20 | XENEXENON PHARMACEUTICALS INC | 250,897 | $3.1B | 1.79% | |
| 21 | ABBVABBVIE INC | 28,900 | $2.8B | 1.62% | |
| 22 | —MISONIX INC | 196,301 | $2.7B | 1.52% | |
| 23 | —ITAMAR MED LTD | 140,524 | $2.6B | 1.49% | |
| 24 | EP3ORASURE TECHNOLOGIES INC | 223,200 | $2.6B | 1.48% | |
| 25 | HUMHUMANA INC | 6,600 | $2.6B | 1.46% | |
| 26 | NVROEURNEVRO CORP | 18,800 | $2.2B | 1.28% | |
| 27 | ISIIONIS PHARMACEUTICALS INC | 36,400 | $2.1B | 1.22% | |
| 28 | AM6AMICUS THERAPEUTICS INC | 127,300 | $1.9B | 1.09% | |
| 29 | SU6SURMODICS INC | 43,978 | $1.9B | 1.08% | |
| 30 | AXNX*AXONICS MODULATION TECHNOLOG | 48,800 | $1.7B | 0.98% | |
| 31 | HZNPHORIZON THERAPEUTICS PUB LTD | 29,600 | $1.6B | 0.94% | |
| 32 | RFLRAFAEL HLDGS INC | 104,737 | $1.5B | 0.86% | |
| 33 | CRSPCRISPR THERAPEUTICS AG | 17,200 | $1.3B | 0.72% | |
| 34 | STAASTAAR SURGICAL CO | 20,428 | $1.3B | 0.72% | |
| 35 | SILKSILK RD MED INC | 27,711 | $1.2B | 0.66% | |
| 36 | FATEFATE THERAPEUTICS INC | 33,000 | $1.1B | 0.65% | |
| 37 | —KADMON HLDGS INC | 200,841 | $1.0B | 0.59% | |
| 38 | —BIOHAVEN PHARMACTL HLDG CO L | 14,000 | $1.0B | 0.58% | |
| 39 | —CONSTELLATION PHARMCETICLS I | 33,400 | $1.0B | 0.57% | |
| 40 | GOSS 5 06/01/27GOSSAMER BIO INC | 1,000,000 | $1.0B | 0.57% | |
| 41 | —VAPOTHERM INC | 21,700 | $889.0M | 0.51% | |
| 42 | DVAXDYNAVAX TECHNOLOGIES CORP | 100,000 | $887.0M | 0.51% | |
| 43 | PRVBUSDPROVENTION BIO INC | 59,900 | $845.0M | 0.48% | |
| 44 | PODDINSULET CORP | 4,000 | $777.0M | 0.44% | |
| 45 | 3M4MASIMO CORP | 3,400 | $775.0M | 0.44% | |
| 46 | AXGNAXOGEN INC | 80,350 | $742.0M | 0.42% | |
| 47 | RVNCEURREVANCE THERAPEUTICS INC | 28,469 | $695.0M | 0.40% | |
| 48 | LYRALYRA THERAPEUTICS INC | 60,670 | $687.0M | 0.39% | |
| 49 | PCRXPACIRA BIOSCIENCES | 12,200 | $640.0M | 0.36% | |
| 50 | —ANTARES PHARMA INC | 229,046 | $629.0M | 0.36% | |
| 51 | BIIBBIOGEN INC | 2,300 | $615.0M | 0.35% | |
| 52 | ENTAENANTA PHARMACEUTICALS INC | 11,500 | $577.0M | 0.33% | |
| 53 | CSTLCASTLE BIOSCIENCES INC | 15,000 | $565.0M | 0.32% | |
| 54 | —HARPOON THERAPEUTICS INC | 30,886 | $512.0M | 0.29% | |
| 55 | INSPINSPIRE MED SYS INC | 5,608 | $488.0M | 0.28% | |
| 56 | RAPTEURRAPT THERAPEUTICS INC | 15,100 | $438.0M | 0.25% | |
| 57 | LRMRLARIMAR THERAPEUTICS INC | 31,170 | $400.0M | 0.23% | |
| 58 | RLMDRELMADA THERAPEUTICS INC | 6,900 | $308.0M | 0.18% | |
| 59 | ARVNARVINAS INC | 6,000 | $201.0M | 0.11% | |
| 60 | INSM 1.75 01/15/25INSMED INC | 180,000 | $174.0M | 0.10% |